China Opens Regulatory Review of Novo Nordisk’s Oral Wegovy in Major Obesity Drug Race
Shanghai, August 29, 2026: China has taken an important regulatory step toward potentially allowing Novo Nordisk’s oral version of Wegovy...
Shanghai, August 29, 2026: China has taken an important regulatory step toward potentially allowing Novo Nordisk’s oral version of Wegovy...